Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Total debt minus cash and cash equivalents
Latest
$-85.72M
↓ 46% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive growthCompressed
Average
$-58.62M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-85.72M | +4.1% |
| 2024 | $-89.42M | +52.7% |
| 2023 | $-188.89M | -524.8% |
| 2022 | $-30.23M | -199.9% |
| 2021 | $-10.08M | +88.1% |
| 2020 | $-84.65M | -496.5% |
| 2019 | $-14.19M | +36.8% |
| 2018 | $-22.46M | -75.2% |
| 2017 | $-12.82M | +73.2% |
| 2016 | $-47.75M | - |